Company · CIK 0001737523 · SIC 8071 — Services-Medical Laboratories · Nasdaq
BioNexus Gene Lab Corp · BGLC
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 13, 2026 AForm 4 → | Aug 14, 5:20 pm EDT | Lee Su-Leng TanChief Executive Officer, Director, 10% Owner | 338,709 | — | — | 338,709 | — | |
| Aug 13, 2026 AForm 4 → | Aug 14, 5:19 pm EDT | Chee Keong YapDirector | 32,258 | — | — | 32,258 | — | |
| Aug 13, 2026 AForm 4 → | Aug 14, 5:18 pm EDT | Hamid Muhammad Azrul Bin AbdulDirector | 32,258 | — | — | 32,258 | — | |
| Aug 13, 2026 AForm 4 → | Aug 14, 5:17 pm EDT | Set Fui ChongChief Financial Officer | 96,774 | — | — | 96,774 | — | |
| Aug 13, 2026 AForm 4 → | Aug 14, 5:14 pm EDT | Jook Yuen LowDirector | 16,129 | — | — | 17,390 | — |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.